Wilmington, Delaware--(Newsfile Corp. - August 13, 2024) - Rigrodsky Law, P.A. is investigating Revance Therapeutics, Inc. ("Revance") (NASDAQ: RVNC) regarding possible breaches of fiduciary duties and other violations of law related to Revance's agreement to be acquired by Crown Laboratories, Inc. Under the terms of the agreement, Revance shareholders will receive $6.66 per share in cash.
To learn more about this investigation and your rights, visit: .
To contact Seth D. Rigrodsky or Gina M. Serra cost free, call or text (302) 295-5310 or email info@rl-legal.com.
Rigrodsky Law, P.A., with offices in Delaware and New York, has recovered hundreds of millions of dollars on behalf of investors and achieved substantial corporate governance reforms in securities fraud and corporate class actions nationwide.
Attorney advertising. Prior results do not guarantee a similar outcome.
Contact:
Rigrodsky Law, P.A.
Seth D. Rigrodsky, Esq.
Gina M. Serra, Esq.
Call or Text: (302) 295-5310
Email: info@rl-legal.com
